2019
DOI: 10.14740/gr1203
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Pancreatitis Leading to Pancreatogenic Diabetes Presenting in Diabetic Ketoacidosis: A Rare Entity

Abstract: Diabetes mellitus type 3c (DM3c) is an uncommon cause of diabetes due to pancreatic pathology. Its prevalence reaches about 5-10% among all diabetics in the Western world, largely due to chronic pancreatitis. DM3c occurs due to the destruction of the endocrine islet cells. Glucagon and insulin levels are both decreased due to the destruction of alpha and beta cells, respectively. This makes the development of diabetic ketoacidosis (DKA) a rare process in patients with DM3c because of the destruction of glucago… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 5 publications
0
9
0
1
Order By: Relevance
“…The role of PERT in this group of patients is inevitable. PERT improves incretin secretion, insulin secretion, and glucose intolerance [4][5][6]. It also aids in the absorption of fat-soluble vitamins A, D, E, and K [6,12].…”
Section: Discussionmentioning
confidence: 99%
“…The role of PERT in this group of patients is inevitable. PERT improves incretin secretion, insulin secretion, and glucose intolerance [4][5][6]. It also aids in the absorption of fat-soluble vitamins A, D, E, and K [6,12].…”
Section: Discussionmentioning
confidence: 99%
“…This indicates insulin resistance reflected by increased homeostatic model assessment of insulin resistance (HOMA-IR) index [ 1 ]. The CP has a serious negative impact on the social and psychological health [ 5 ]. Further, the risk of pancreatic cancer in CP patients increased almost eightfold [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Subclinical disorders of acid-base balance, according to the latest scientific data, have the following consequences for the patient [10]: directly affect the development of chronic pain syndrome, which is difficult to stop [11], worsen the effectiveness of the therapy involved, lead to chronicity of pathological processes [12], affect quality of life in the long-term period, provoke more frequent development of CP complications in comorbidity with T2DM [13].…”
Section: Introductionmentioning
confidence: 99%